Skip to content

SCHEDULE 13G/AAccepted Nov 14, 4:30 PM ET

Lyell Immunopharma, Inc. SCHEDULE 13G/A

ARCH Venture Fund IX, L.P.

Accepted (ET)

4:30 PM

Nov 14, 2025

Filed

Nov 14, 2025

Documents

2

Size

65.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.